The Pass-Through Trap
Lithium carbonate posted its sharpest weekly decline of 2026 and LFP ESS cells registered zero pass-through. SMM's 280 Ah format ticked up. Three consecutive weeks of this pattern now have a mechanism: iron phosphate rose ~40% in H1, cathode processing fees increase August 1, and Q2 absorption tightened. The cost stack decoupled from its most-watched input sometime in H1, and any cell-price model still running lithium as the primary variable is already broken. Buyers planning to lever the carbonate decline into procurement concessions will find the other side of the table unmoved.
The Pass-Through Trap
Lithium carbonate posted its sharpest weekly decline of 2026 and LFP ESS cells registered zero pass-through. SMM's 280 Ah format ticked up. Three consecutive weeks of this pattern now have a mechanism: iron phosphate rose ~40% in H1, cathode processing fees increase August 1, and Q2 absorption tightened. The cost stack decoupled from its most-watched input sometime in H1, and any cell-price model still running lithium as the primary variable is already broken. Buyers planning to lever the carbonate decline into procurement concessions will find the other side of the table unmoved.
The Non-Lithium Floor
Iron phosphate rose from approximately RMB 10,000/MT at year-end 2025 to RMB 14,500–15,000/MT by mid-July, per SMM's H1 LFP cathode review (July 13) and Hunan Yuneng's own client letter (SMM, July 16). The driver is sulfur, not lithium. Hunan Yuneng states iron phosphate now accounts for over 70% of LFP processing fees and announced a +RMB 2,000/MT processing fee increase across all LFP product series effective August 1.
The settlement basis is shifting underneath this. Per SMM's July 13 review, some leading and mid-sized cell manufacturers began accepting iron-phosphate-linked settlement in April–May 2026, using SMM's monthly average iron phosphate price as the benchmark. Adoption is partial. Most tier-one and tier-two battery plants have not switched. But the model exists, and SMM flags its expansion as "the core variable" for H2.
A contract indexed only to lithium carbonate captures one input while the other moves against you. Lithium carbonate fell 7.2% WoW through late July. Iron phosphate processing fees rose. If your supplier's cathode costs are settling on an iron phosphate index upstream while your cell contract references lithium, that divergence will compress someone's margin. The question is whose, and whether your contract makes that explicit or leaves it to the next negotiation cycle.
Source Trail
